Song Hong Fang bought CGON
January 29, 2024 · Form 4 insider transaction
Song Hong Fang bought 350,771 shares of CG Oncology, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
350,771
Price
N/A
Total value
N/A
InsiderSong Hong Fang
RoleDirector
CompanyCG Oncology, Inc. (CGON)
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateJanuary 29, 2024
Filing dateJanuary 31, 2024
Shares owned after350,771
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.